caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1922096130

Sergio XiquesM.D.

Hematology-OncologyMiami, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Sergio Xiques's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
52183
COMPLETE BIO SOLUTIONS INC1746
CMLAB INC1362
NPI 11140776741359
PALM SPRINGS GENERAL HOSPITAL INC NEW CORPORATION1241
Ambulatory Diagnostic Center Inc
Independent Diagnostic Testing Facility (IDTF) · Coral Gables, FL
1113
Med Health Clinical Lab Llc
Clinical Laboratory · Doral, FL
1156
Carlos Guida
Hematology-Oncology · Miami, FL
1140
HIALEAH HOSPITAL INC.1125
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
138
Unique beneficiaries
—
Total services
322
Distinct HCPCS
4
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 737 Hematology-Oncology providers in FL — bottom quintile (cohort median 1,932).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,691
Beneficiaries
—
Total drug cost
$3.2M
Distinct drugs
27
Brand share
17.0%
Top prescribed drugs
Anastrozole461 claims
Bicalutamide207 claims
Hydroxyurea178 claims
Prednisone135 claims
Anagrelide Hcl104 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
146
By payment type
Food and Beverage$3K
Education$360